Literature DB >> 20129961

Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.

Hassan Zaraket1, Reiko Saito, Yasushi Suzuki, Tatiana Baranovich, Clyde Dapat, Isolde Caperig-Dapat, Hiroshi Suzuki.   

Abstract

The emergence and widespread occurrence of antiviral drug-resistant seasonal human influenza A viruses, especially oseltamivir-resistant A/H1N1 virus, are major concerns. To understand the genetic background of antiviral drug-resistant A/H1N1 viruses, we performed full genome sequencing of prepandemic A/H1N1 strains. Seasonal influenza A/H1N1 viruses, including antiviral-susceptible viruses, amantadine-resistant viruses, and oseltamivir-resistant viruses, obtained from several areas in Japan during the 2007-2008 and 2008-2009 influenza seasons were analyzed. Sequencing of the full genomes of these viruses was performed, and the phylogenetic relationships among the sequences of each individual genome segment were inferred. Reference genome sequences from the Influenza Virus Resource database were included to determine the closest ancestor for each segment. Phylogenetic analysis revealed that the oseltamivir-resistant strain evolved from a reassortant oseltamivir-susceptible strain (clade 2B) which circulated in the 2007-2008 season by acquiring the H275Y resistance-conferring mutation in the NA gene. The oseltamivir-resistant lineage (corresponding to the Northern European resistant lineage) represented 100% of the H1N1 isolates from the 2008-2009 season and further acquired at least one mutation in each of the polymerase basic protein 2 (PB2), polymerase basic protein 1 (PB1), hemagglutinin (HA), and neuraminidase (NA) genes. Therefore, a reassortment event involving two distinct oseltamivir-susceptible lineages, followed by the H275Y substitution in the NA gene and other mutations elsewhere in the genome, contributed to the emergence of the oseltamivir-resistant lineage. In contrast, amantadine-resistant viruses from the 2007-2008 season distinctly clustered in clade 2C and were characterized by extensive amino acid substitutions across their genomes, suggesting that a fitness gap among its genetic components might have driven these mutations to maintain it in the population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20129961      PMCID: PMC2849588          DOI: 10.1128/JCM.01532-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.

Authors:  P Kramarz; Dominique Monnet; A Nicoll; C Yilmaz; B Ciancio
Journal:  Euro Surveill       Date:  2009-02-05

2.  The evolution of influenza resistance and treatment.

Authors:  David M Weinstock; Gianna Zuccotti
Journal:  JAMA       Date:  2009-03-02       Impact factor: 56.272

3.  Isolation of oseltamivir-resistant influenza A/H1N1 virus of different origins in Yokohama City, Japan, during the 2007-2008 influenza season.

Authors:  Chiharu Kawakami; Masatsugu Obuchi; Miwako Saikusa; Yuzo Noguchi; Makoto Ujike; Takato Odagiri; Mami Iwata; Takahiro Toyozawa; Masato Tashiro
Journal:  Jpn J Infect Dis       Date:  2009-01       Impact factor: 1.362

Review 4.  Pandemic and seasonal influenza: therapeutic challenges.

Authors:  Matthew J Memoli; David M Morens; Jeffery K Taubenberger
Journal:  Drug Discov Today       Date:  2008-05-15       Impact factor: 7.851

5.  The influenza virus enigma.

Authors:  Rachelle Salomon; Robert G Webster
Journal:  Cell       Date:  2009-02-06       Impact factor: 41.582

6.  Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Authors:  Nila J Dharan; Larisa V Gubareva; John J Meyer; Margaret Okomo-Adhiambo; Reginald C McClinton; Steven A Marshall; Kirsten St George; Scott Epperson; Lynnette Brammer; Alexander I Klimov; Joseph S Bresee; Alicia M Fry
Journal:  JAMA       Date:  2009-03-02       Impact factor: 56.272

7.  Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.

Authors:  Jairo Gooskens; Marcel Jonges; Eric C J Claas; Adam Meijer; Peterhans J van den Broek; Aloyj M Kroes
Journal:  JAMA       Date:  2009-03-02       Impact factor: 56.272

8.  Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.

Authors:  Siri H Hauge; Susanne Dudman; Katrine Borgen; Angie Lackenby; Olav Hungnes
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

9.  Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States.

Authors:  Martha I Nelson; Laurel Edelman; David J Spiro; Alex R Boyne; Jayati Bera; Rebecca Halpin; Naomi Sengamalay; Elodie Ghedin; Mark A Miller; Lone Simonsen; Cecile Viboud; Edward C Holmes
Journal:  PLoS Pathog       Date:  2008-08-22       Impact factor: 6.823

10.  Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918.

Authors:  Martha I Nelson; Cécile Viboud; Lone Simonsen; Ryan T Bennett; Sara B Griesemer; Kirsten St George; Jill Taylor; David J Spiro; Naomi A Sengamalay; Elodie Ghedin; Jeffery K Taubenberger; Edward C Holmes
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

View more
  30 in total

1.  Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase.

Authors:  Nicole M Bouvier; Saad Rahmat; Natalie Pica
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  The global spread of drug-resistant influenza.

Authors:  Dennis L Chao; Jesse D Bloom; Beth F Kochin; Rustom Antia; Ira M Longini
Journal:  J R Soc Interface       Date:  2011-08-24       Impact factor: 4.118

Review 3.  Structural basis for proton conduction and inhibition by the influenza M2 protein.

Authors:  Mei Hong; William F DeGrado
Journal:  Protein Sci       Date:  2012-10-09       Impact factor: 6.725

Review 4.  Variability among the neuraminidase, non-structural 1 and PB1-F2 proteins in the influenza A virus genome.

Authors:  William G Dundon
Journal:  Virus Genes       Date:  2012-01-20       Impact factor: 2.332

5.  Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers.

Authors:  Rami Musharrafieh; Chunlong Ma; Jun Wang
Journal:  Antiviral Res       Date:  2018-03-06       Impact factor: 5.970

6.  Molecular characterization of a novel reassortant H1N2 influenza virus containing genes from the 2009 pandemic human H1N1 virus in swine from eastern China.

Authors:  Xiuming Peng; Haibo Wu; Lihua Xu; Xiaorong Peng; Linfang Cheng; Changzhong Jin; Tiansheng Xie; Xiangyun Lu; Nanping Wu
Journal:  Virus Genes       Date:  2016-03-15       Impact factor: 2.332

7.  Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.

Authors:  Elena A Govorkova; Tatiana Baranovich; Patrick Seiler; Jianling Armstrong; Andrew Burnham; Yi Guan; Malik Peiris; Richard J Webby; Robert G Webster
Journal:  Antiviral Res       Date:  2013-02-28       Impact factor: 5.970

8.  Ceramide Suppresses Influenza A Virus Replication In Vitro.

Authors:  Nadia Soudani; Rouba Hage-Sleiman; Walid Karam; Ghassan Dbaibo; Hassan Zaraket
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

9.  Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection.

Authors:  Qiang Liu; Hai-rong Xiong; Li Lu; Yuan-yuan Liu; Fan Luo; Wei Hou; Zhan-qiu Yang
Journal:  Acta Pharmacol Sin       Date:  2013-06-17       Impact factor: 6.150

10.  Structural basis for the function and inhibition of an influenza virus proton channel.

Authors:  Amanda L Stouffer; Rudresh Acharya; David Salom; Anna S Levine; Luigi Di Costanzo; Cinque S Soto; Valentina Tereshko; Vikas Nanda; Steven Stayrook; William F DeGrado
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.